PGC-1α attenuates hydrogen peroxide-induced apoptotic cell death by upregulating Nrf-2 via GSK3β inactivation mediated by activated p38 in HK-2 Cells.
Choi HI, Kim HJ, Park JS, Kim IJ, Bae EH, Ma SK, Kim SW. · Scientific reports · 2017
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
The study identified a possible biological mechanism for hydrogen rather than demonstrating a clinical treatment effect.
Molecular hydrogen kidney health study 2017: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This in vitro or cellular study examined PGC-1α attenuates hydrogen peroxide-induced apoptotic cell death by upregulating Nrf-2 via GSK3β inactivation mediated by activated p38 in HK-2 Cells. The abstract describes Cell culture / in vitro model. Using inhibitor of p38, we found that regulation of the p38/glycogen synthase kinase 3β (GSK3β)/Nrf-2 axis was involved in the protective effects of PGC-1α.
How to read this paper: This is a mechanism-focused study. It investigates a biological target or pathway through which molecular hydrogen may act; it does not establish clinical benefit in people.
Publication: Choi HI, Kim HJ, Park JS, Kim IJ, Bae EH, Ma SK, Kim SW., Scientific reports, 2017.
What the researchers studied
The researchers examined how molecular hydrogen related to kidney and renal health. The available structured record did not clearly identify one primary outcome, so the original source should be checked for the complete endpoint definitions.
What effects did molecular hydrogen have?
Observed mechanistic effect: Using inhibitor of p38, we found that regulation of the p38/glycogen synthase kinase 3β (GSK3β)/Nrf-2 axis was involved in the protective effects of PGC-1α. The peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α) is a master player that regulates mitochondrial biogenesis and the antioxidant response. The finding identifies a possible biological target or pathway through which molecular hydrogen may act. It does not establish clinical benefit in people.
Why these findings matter
This research helps explain how hydrogen may act at a biological level. It strengthens the scientific rationale for future therapeutic studies, but it does not show that patients will experience a clinical benefit.
How strong is this evidence?
This is laboratory or cellular evidence. It is useful for understanding mechanisms and biological targets, but it does not establish clinical benefit in people. Randomization: Not applicable.
Technical study details
- Publication type: In vitro or cellular study
- Evidence type: Laboratory or cellular evidence
- Research model or population: Cellular or tissue model
- Randomized: Not applicable
- Hydrogen method: Other or not reported
Limitations and safety
Important limitations: Laboratory findings may not translate directly to living organisms or clinical outcomes.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.